Do gender, age or lifestyle factors affect responses to antimuscarinic treatment in overactive bladder patients?

International Journal of Clinical Practice

Volumn 64, Issue 9, 2010, Pages 1287-1293

  Schneider, T ^a   Marschall Kehrel, D ^b   Hanisch, J U ^c   Michel, M C ^d  

^a Praxisklinik Urologie Rhein Ruhr   (Germany)

^b Urological Practice   (Germany)

^c BAYER AG   (Germany)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DARIFENACIN;

ADULT; ARTICLE; CLINICAL FEATURE; CONSTIPATION; CORRELATION ANALYSIS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MICTURITION; NOCTURIA; OBESITY; OVERACTIVE BLADDER; PREVALENCE; PRIORITY JOURNAL; TREATMENT RESPONSE; URINE INCONTINENCE; XEROSTOMIA;

AGE FACTORS; AGED; ALCOHOL DRINKING; COFFEE; FEMALE; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; MUSCARINIC ANTAGONISTS; OBESITY; RISK FACTORS; SEX FACTORS; SMOKING; TREATMENT OUTCOME; URINARY BLADDER, OVERACTIVE; URINARY INCONTINENCE;

EID: 77954642840     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2010.02442.x     Document Type: Article

References (30)

1. Abrams P, Cardozo L, Fall M et al. The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Neurourol Urodyn 2002 21 : 167 178. (Pubitemid 34195211)
2. Milsom I, Abrams P, Cardozo L, Roberts RG, Thüroff JW, Wein AJ. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study BJU Int 2001 87 : 760 766.
3. Stewart WF, van Rooyen JB, Cundiff GW et al. Prevalence and burden of overactive bladder in the United States. World J Urol 2003 20 : 327 336.
4. Irwin DE, Milsom I, Hunskaar S et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 2006 50 : 1306 1315.
5. Michel MC, Chapple CR. Basic mechanisms of urgency: basic and clinical evidence. Eur Urol 2009 56 : 298 308.
6. Goepel M, Hoffmann J, Piro M, Rübben H, Michel MC. Prevalence and physician awareness of symptoms of urinary bladder dysfunction. Eur Urol 2002 41 : 234 239.
7. Michel MC, Schneider T, Krege S, Goepel M. Do gender or age affect the efficacy and safety of tolterodine? J Urol 2002 168 : 1027 1031.
8. Michel MC, Wetterauer U, Vogel M, de la Rosette JJMCH. Cardiovascular safety and overall tolerability of solifenacin in routine clinical use. Drug Saf 2008 31 : 505 514.
9. Brown JS, Seeley DG, Fong J, Black DM, Ensrud KE, Grady D. Urinary incontinence in older women: who is at risk? Obstet Gynecol 1996 87 : 715 721.
10. Espino DV, Palmer RF, Miles TP, Mouton CP, Lichtenstein MJ, Markides KP. Prevalence and severity of urinary incontinence in elderly Mexican-American women. J Am Geriatr Soc 2003 51 : 1580 1586.
11. Hannestad YS, Rortveit G, Daltveit AK, Hunskaar S. Are smoking and other lifestyle factors associated with female urinary incontinence? The Norwegian EPINCONT study BJOG 2003 110 : 247 254.
12. Melville JL, Katon W, Delaney K, Newton K. Urinary incontinence in US women. A population-based study. Arch Intern Med 2005 165 : 537 542. (Pubitemid 40344385)
13. Dallosso HM, McGrother CW, Matthews RJ, Donaldson MMK. The association of diet and other lifestyle factors with overactive bladder and stress incontinence: a longitudinal study in women. BJU Int 2003 92 : 69 77.
14. Arya LA, Myers DL, Jackson ND. Dietary caffeine intake and the risk for detrusor instability: a case-control study. Obstet Gynecol 2000 96 : 85 9.
15. Shiri R, Hakama M, Häkkinen J et al. The effects of lifestyle factors on the incidence of nocturia. J Urol 2008 180 : 2059 2062.
16. Brown JS, Grady D, Ouslander JG, Herzog AR, Varner E, Posner SF. Prevalence of urinary incontinence and associated risk factors in postmenopausal women. Obstet Gynecol 1999 94 : 66 70.
17. Dallosso HM, Matthews RJ, McGrother CW, Donaldson MMK, Shaw C. The association of diet and other lifestyle factors with the onset of overactive bladder: a longitudinal study in men. Public Health Nutr 2004 7 : 885 891.
18. Wyman JF, Burgio KL, Newman DK. Practical aspects of lifestyle modifications and behavioural interventions in the treatment of overactive bladder and urgency urinary incontinence. Int J Clin Pract 2009 63 : 1177 1191.
19. Hashim H, Abrams P. How should patients with an overactive bladder manipulate their fluid intake? BJU Int 2008 102 : 62 6.
20. Natarajan V, Master V, Ogan K. Effects of obesity and weight loss in patients with nononcological urological disease. J Urol 2009 181 : 2424 2429.
21. Chapple CR, Khullar V, Gabriel Z, Muston D, Biton CE, Weinstein D. The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis. Eur Urol 2008 54 : 543 562.
22. Novara G, Galfano A, Secco S et al. A systematic review and meta-analysis of randomized controlled trials with antimuscarinic drugs for overactive bladder. Eur Urol 2008 54 : 740 764.
23. Michel MC, Barendrecht MM. Physiological and pathological regulation of the autonomic control of urinary bladder contractility. Pharmacol Ther 2008 117 : 297 312.
24. Witte LPW, Peschers U, Vogel M, de la Rosette JJMCH, Michel MC. Does the number of previous vaginal deliveries affect overactive bladder symptoms or their response to treatment? LUTS 2009 1 : 82 7.
25. 3 selective receptor antagonist, in the treatment of overactive bladder. BJU Int 2005 95 : 993 1001.
26. 3 selective receptor antagonist. Eur Urol 2005 48 : 471 477.
27. Michel MC, Oelke M, Zinner N. Novel muscarinic antagonists to treat incontinence and/or overactive bladder. Drug Discov Today Ther Strat 2005 2 : 1 6.
28. Michel MC, Oelke M, Goepel M, Beck E, Burkart M. Relationships among symptoms, bother, and treatment satisfaction in overactive bladder patients. Neurourol Urodyn 2007 26 : 190 195.
29. Michel MC, de la Rosette JJMCH, Piro M, Schneider T. Comparison of symptom severity and treatment response in patients with incontinent and continent overactive bladder. Eur Urol 2005 48 : 110 115.
30. Brodde O-E, Michel MC. Adrenergic and muscarinic receptors in the human heart. Pharmacol Rev 1999 51 : 651 689.